低剂量胆固醇可改善多克索鲁比通过促进自溶酶体降解来改善心脏毒性
相关实验视频
Updated: Jun 27, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.5K
Ying Peng1,2, Zhonggen Li1, Jianchao Zhang1
1Centre for Cardiovascular Diseases, Henan Key Laboratory of Hereditary Cardiovascular Diseases The First Affiliated Hospital of Zhengzhou University, Zhengzhou University Zhengzhou China.
Journal of the American Heart Association
|May 3, 2024
概括
低剂量胆固醇恢复了自并显著改善了心脏功能,提供了一种有前途的新疗法,以减少多克索鲁比辛心脏毒性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- doxorubicin 化疗可以引起心脏毒性,治疗选择有限.
- 德克斯拉佐是唯一经批准的药物,但具有二次癌症的风险.
- 科尔奇辛因其抗炎和抗氧化特性而闻名,已显示出对心血管的益处.
研究的目的:
- 调查低剂量胆固醇在减轻多克索鲁比诱导心脏毒性的有效性.
- 阐明菌素影响心肌细胞自的机制.
主要方法:
- doxorubicin 用于诱导心力衰竭模型在体内和体外.
- 低剂量胆固醇 (每天0.1毫克/公斤) 被用于评估其影响.
- 测量了心脏功能,特别是左心室喷射分数.
主要成果:
- 多克索鲁比损害了自流,导致线粒体损伤和反应性氧物种的积累.
- 低剂量胆固醇治疗显著改善了心脏功能 (LVEF从43.75%增加到57.07%).
- 科尔奇辛促进了自溶酶体的降解,降低了心脏毒性.
结论:
- 在多克索鲁比引起的心脏毒性的背景下,低剂量胆固醇有效地恢复了自活动.
- 科尔奇辛是一种有前途的治疗策略,可以抵消多克索鲁比辛对心脏的有害影响.
相关概念视频
Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370

